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We read with interest the Editorial in CMI [1]
concerning the heteroresistance of organisms such
as Staphylococcus aureus, coagulase-negative
staphylococci, Acinetobacter baumannii, Mycobacte-
rium tuberculosis, Streptococcus pneumoniae, Entero-
coccus faecium and Cryptococcus neoformans. The
Editorial focused especially on heteroresistant
vancomycin-intermediate S. aureus and heterore-
sistant glycopeptide-intermediate S. aureus
strains. We would like to draw attention to
another heteroresistance phenomenon that we
observed among methicillin-resistant S. aureus
(MRSA) isolates in Turkiye Yuksek Ihtisas
Teaching and Research Hospital, Ankara, Turkey
[2].
MRSA isolates from various clinical samples
obtained from hospitalised patients at Turkiye
Yuksek Ihtisas Teaching and Research Hospital
were identified by Gram’s stain, tube coagulase
tests and oxacillin agar screening tests. Erythro-
mycin heteroresistance was determined using a
standard disk method [3]. After realising that tiny
colonies grew in the erythromycin inhibition
zone, we decided to test the effect of this hetero-
resistance on the expression of inducible clinda-
mycin resistance using D-tests [4]. In brief, a 15-lg
erythromycin disk was placed 15 mm from the
centre of a 2-lg clindamycin disk. Inhibition of the
circular zone around the clindamycin disk (i.e.,
flattening of the zone towards the erythromycin
disk) was considered to be a positive indication of
inducible clindamycin resistance.
The results of detailed studies with these
erythromycin-heteroresistant isolates were as
follows: (i) colonies growing within the erythro-
mycin inhibition zones were so tiny and so few
in number that they were hardly visible after
incubation for 24 h at 37C, and the isolate could
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easily have been evaluated as erythromycin-sen-
sitive; (ii) after the same plates were incubated
at 37C for a further 24 h, the intra-zone colonies
became more visible; (iii) using the double-disk-
approximation method, these isolates showed an
inducible clindamycin resistance phenotype,
which was more visible after incubation at 37C
for 48 h; (iv) when the erythromycin disk-diffu-
sion test was performed with a heavier inoculum
(e.g., a McFarland turbidity of 1 or 2), confluent
growth was observed in the erythromycin inhibi-
tion zone; and (v) the colonies growing within the
erythromycin inhibition zone were of varying
sizes, and there was no zone around the disk
when the erythromycin disk-diffusion suscepti-
bility test was repeated with pure cultures of
these inter-zone colonies (i.e., the cultures were
fully resistant to erythromycin). The size of the
colonies did not influence the results, and all the
colonies also showed a D-zone around a clinda-
mycin disk. Repeated studies using the same
strains yielded identical results.
In conclusion, in order to identify such erythro-
mycin-heteroresistant MRSA strains, all MRSA
isolates should be tested by the disk-approxima-
tion method, using erythromycin and clindamy-
cin disks. The plates should be examined
carefully for the existence of tiny colonies, with
re-incubation for a further 24 h if necessary.
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